Market revenue in 2023 | USD 154.6 million |
Market revenue in 2030 | USD 226.3 million |
Growth rate | 5.6% (CAGR from 2023 to 2030) |
Largest segment | Frozen nondonor |
Fastest growing segment | Frozen Nondonor |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Fresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen Donor |
Key market players worldwide | Bayer AG, Cook Medical, Merck KGaA, Ferring, FUJIFILM Holdings Corp, Genea Biomedx, Merck & Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB ADR, Boston Scientific Corp, Nova IVF, Fortis Healthcare, RMA Network, TFP Fertility Group, US Fertility |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro fertilization market will help companies and investors design strategic landscapes.
Frozen nondonor was the largest segment with a revenue share of 48.25% in 2023. Horizon Databook has segmented the Brazil in vitro fertilization market based on fresh nondonor, frozen nondonor, fresh donor, frozen donor covering the revenue growth of each sub-segment from 2018 to 2030.
The demand for IVF treatments in Brazil has been steadily increasing. Factors such as delayed pregnancies, rising infertility rates, and awareness about fertility treatments contribute to the growing demand for IVF services. Brazil is home to numerous advanced fertility clinics and medical facilities that offer IVF services.
These clinics are equipped with advanced technology and have highly skilled medical professionals who specialize in reproductive medicine. In 2015, there was an increase in severe birth defects due to Zika virus infection.
Brazilian Health Regulatory Agency (ANVISA) recommended testing for the virus, since March 2016, in all women going through reproduction treatment, before gamete collection. The cost of IVF treatments in Brazil can vary depending on various factors like the clinic, location, specific treatment protocols, and additional services.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil in vitro fertilization market , including forecasts for subscribers. This country databook contains high-level insights into Brazil in vitro fertilization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account